177 related articles for article (PubMed ID: 19805921)
41. Intravenous amiodarone used alone or in combination with digoxin for life-threatening supraventricular tachyarrhythmia in neonates and small infants.
Dilber E; Mutlu M; Dilber B; Aslan Y; Gedik Y; Celiker A
Pediatr Emerg Care; 2010 Feb; 26(2):82-4. PubMed ID: 20093999
[TBL] [Abstract][Full Text] [Related]
42. Fetal supraventricular tachycardia and hydrops fetalis: combined intensive, direct, and transplacental therapy.
Hallak M; Neerhof MG; Perry R; Nazir M; Huhta JC
Obstet Gynecol; 1991 Sep; 78(3 Pt 2):523-5. PubMed ID: 1870815
[TBL] [Abstract][Full Text] [Related]
43. Antenatal antiarrhythmic treatment for fetal tachyarrhythmias: a study protocol for a prospective multicentre trial.
Miyoshi T; Maeno Y; Sago H; Inamura N; Yasukochi S; Kawataki M; Horigome H; Yoda H; Taketazu M; Shozu M; Nii M; Hagiwara A; Kato H; Shimizu W; Shiraishi I; Sakaguchi H; Ueda K; Katsuragi S; Ikeda T; Yamamoto H; Hamasaki T;
BMJ Open; 2017 Aug; 7(8):e016597. PubMed ID: 28851790
[TBL] [Abstract][Full Text] [Related]
44. Review of diagnosis, treatment, and outcome of fetal atrial flutter compared with supraventricular tachycardia.
Krapp M; Kohl T; Simpson JM; Sharland GK; Katalinic A; Gembruch U
Heart; 2003 Aug; 89(8):913-7. PubMed ID: 12860871
[TBL] [Abstract][Full Text] [Related]
45. Current role of pharmacologic therapy for patients with paroxysmal supraventricular tachycardia.
Basta M; Klein GJ; Yee R; Krahn A; Lee J
Cardiol Clin; 1997 Nov; 15(4):587-97. PubMed ID: 9403162
[TBL] [Abstract][Full Text] [Related]
46. Management of fetal tachyarrhythmia based on superior vena cava/aorta Doppler flow recordings.
Fouron JC; Fournier A; Proulx F; Lamarche J; Bigras JL; Boutin C; Brassard M; Gamache S
Heart; 2003 Oct; 89(10):1211-6. PubMed ID: 12975422
[TBL] [Abstract][Full Text] [Related]
47. Prenatal ultrasound may predict fetal response to therapy in non-hydropic fetuses with supraventricular tachycardia.
Jouannic JM; Le Bidois J; Fermont L; Villain E; Mahieu-Caputo D; Dumez Y; Dommergues M
Fetal Diagn Ther; 2002; 17(2):120-3. PubMed ID: 11844918
[TBL] [Abstract][Full Text] [Related]
48. [Combination therapy for fetal supraventricular tachycardia with flecainide and digoxin].
Anderer G; Hellmeyer L; Tekesin I; Schmidt S
Z Geburtshilfe Neonatol; 2005 Feb; 209(1):34-7. PubMed ID: 15731979
[TBL] [Abstract][Full Text] [Related]
49. [Treatment of foetal supraventricular tachycardia with antiarrhythmic medication administered through the umbilical vein].
Roest AA; Vandenbussche FP; Klumper FJ; Oepkes D; Rijlaarsdam ME; Blom NA
Ned Tijdschr Geneeskd; 2008 Feb; 152(7):389-92. PubMed ID: 18380387
[TBL] [Abstract][Full Text] [Related]
50. [Hydrops fetalis in tachycardia: diagnostic and therapeutic procedures].
Karrer G; Baumann H; Vetter K; Dudenhausen J; Huch A; Arbenz U
Gynakol Rundsch; 1990; 30(1):28-39. PubMed ID: 2189795
[TBL] [Abstract][Full Text] [Related]
51. The efficacy of flecainide versus digoxin in the management of fetal supraventricular tachycardia.
Frohn-Mulder IM; Stewart PA; Witsenburg M; Den Hollander NS; Wladimiroff JW; Hess J
Prenat Diagn; 1995 Dec; 15(13):1297-302. PubMed ID: 8710768
[TBL] [Abstract][Full Text] [Related]
52. Successful treatment of refractory supraventricular tachycardia by repeat intravascular injection of amiodarone in a fetus with hydrops.
Mangione R; Guyon F; Vergnaud A; Jimenez M; Saura R; Horovitz J
Eur J Obstet Gynecol Reprod Biol; 1999 Sep; 86(1):105-7. PubMed ID: 10471151
[TBL] [Abstract][Full Text] [Related]
53. Role of amiodarone in the treatment of fetal supraventricular tachyarrhythmias and hydrops fetalis.
Khositseth A; Ramin KD; O'Leary PW; Porter CJ
Pediatr Cardiol; 2003; 24(5):454-6. PubMed ID: 14627312
[TBL] [Abstract][Full Text] [Related]
54. Management of Fetal Supraventricular Tachycardia: Case Series from a Tertiary Perinatal Cardiac Center.
Broom E; Thomas JT; Petersen S; Gooi A; Ward C; Gardener G; Kostner K; Lee-Tannock A; Kumar S
Fetal Diagn Ther; 2021; 48(11-12):794-800. PubMed ID: 34753148
[TBL] [Abstract][Full Text] [Related]
55. Transplacental fetal therapy for junctional ectopic tachycardia.
Ishikawa K; Kikuchi A; Matsui H; Tamaru S; Imada S; Horikoshi T; Takagi K
J Clin Ultrasound; 2012 Feb; 40(2):119-23. PubMed ID: 21935962
[TBL] [Abstract][Full Text] [Related]
56. Postnatal Outcomes of Fetal Supraventricular Tachycardia: a Multicenter Study.
Hinkle KA; Peyvandi S; Stiver C; Killen SAS; Weng HY; Etheridge SP; Puchalski MD
Pediatr Cardiol; 2017 Oct; 38(7):1317-1323. PubMed ID: 28664446
[TBL] [Abstract][Full Text] [Related]
57. Rate-based management of fetal supraventricular tachycardia.
Guntheroth WG; Cyr DR; Shields LE; Nghiem HV
J Ultrasound Med; 1996 Jun; 15(6):453-8. PubMed ID: 8738990
[TBL] [Abstract][Full Text] [Related]
58. Supraventricular tachycardias in the first year of life: what is the best pharmacological treatment? 24 years of experience in a single centre.
Capponi G; Belli G; Giovannini M; Remaschi G; Brambilla A; Vannuccini F; Favilli S; Porcedda G; De Simone L
BMC Cardiovasc Disord; 2021 Mar; 21(1):137. PubMed ID: 33722203
[TBL] [Abstract][Full Text] [Related]
59. Pharmacologic management of supraventricular tachycardias in children. Part 2: Atrial flutter, atrial fibrillation, and junctional and atrial ectopic tachycardia.
Luedtke SA; Kuhn RJ; McCaffrey FM
Ann Pharmacother; 1997 Nov; 31(11):1347-59. PubMed ID: 9391691
[TBL] [Abstract][Full Text] [Related]
60. Drug treatment of fetal tachycardias.
Oudijk MA; Ruskamp JM; Ambachtsheer BE; Ververs TF; Stoutenbeek P; Visser GH; Meijboom EJ
Paediatr Drugs; 2002; 4(1):49-63. PubMed ID: 11817986
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
